Product involved: Mucosamin Spray
Burning Mouth Syndrome
Study:
To assess and validate the use of Mucosamin Spray to facilitate the healing of the oral mucosa, and therefore to reduce any undesirable effects induced by the inflammation and ulceration of the mucous membranes in Burning Mouth Syndrome (BMS) secondary to local or systemic conditions.
Design:
Total: 60 patients were randomized in 2 groups:
- Group A: 30 patients (15 males and 15 females) – local application of Mucosamin Spray 3 times a day after meals for 1 month.
- Group B: 30 patients (15 males and 15 females) – oral rinses of sodium bicarbonate diluted in water (1 glass of water + 2 spoons of baking soda).
Measurements:
- mucosal objectivity by use of the Oral Mucositis Assessment Scale (OMAS), assessed by means of an otorhinolaryngological examination after 7, 15 and 30 days from inclusion.
- degree of patient satisfaction quantified on a scale of 1 to 4 (negative, modest, good and excellent).
- Pain measured with a one-dimensional verbal rating scale (VRS) (0 no pain, 1 mild pain, 2 moderate pain, 3 strong pain, 4 unbearable pain).
- All the measurements were divided into 2 groups: male and females and performed at T0 – T7 days, T15 days and T30 days.
Improvement of oral mucosal objectivity (%)
Subject improvement (%)
Clinical Results
• Significantly promote patients’ healing and compliance.
• Reduce pain sensation.
• A more frequent improvement in mucosal objectivity already in the short term.
• Mucosamin seems improve the degree of satisfaction, especially among females.
